Benefits and Harms of the CMS Ruling on Next-Generation Sequencing

This Viewpoint discusses the positive and negative implications of the US national coverage determination for reimbursement for next-generation sequencing by the Centers for Medicare & Medicaid Services.

https://ift.tt/2N5PB3D